Latest Articles
Kerry endometriosis sufferer approved for treatment abroad under new scheme – ‘Reform is happening’ - The Irish Independent
Kerry endometriosis sufferer approved for treatment abroad under new scheme – ‘Reform is happening’ The Irish Independent
Published: March 5, 2026, 5 p.m.
Short-Term Vaginal Estrogen Therapy Does Not Increase Risks of Endometrial Cancer Recurrence - The ASCO Post
Short-Term Vaginal Estrogen Therapy Does Not Increase Risks of Endometrial Cancer Recurrence The ASCO Post
Published: March 5, 2026, 4:20 p.m.
Montu advocates better care for Australian women impacted by endometriosis - retailpharmacymagazine.com.au
Montu advocates better care for Australian women impacted by endometriosis retailpharmacymagazine.com.au
Published: March 5, 2026, 3 a.m.
Endometriosis Awareness Undergarments - Trend Hunter
Endometriosis Awareness Undergarments Trend Hunter
Published: March 5, 2026, 2:23 a.m.
Endometriosis: Fapohunda leads charge for compassion, policy reform - The Sun Nigeria
Endometriosis: Fapohunda leads charge for compassion, policy reform The Sun Nigeria
Published: March 4, 2026, 11:36 p.m.
Ananda Pharma to Begin Dosing in NHS-Backed CBD Endometriosis Trial - Cannabis Health News
Ananda Pharma to Begin Dosing in NHS-Backed CBD Endometriosis Trial Cannabis Health News
Published: March 4, 2026, 9:33 p.m.
'I had never experienced pain like it': Why it's time we stopped telling women that this agony is normal... - Daily Mail
'I had never experienced pain like it': Why it's time we stopped telling women that this agony is normal... Daily Mail
Published: March 4, 2026, 7:54 p.m.
Endometriosis stole my ‘normal’ and gave me a lifetime of diagnoses and pain - NOW Toronto
Endometriosis stole my ‘normal’ and gave me a lifetime of diagnoses and pain NOW Toronto
Published: March 4, 2026, 4:08 p.m.
Endometriosis Pain Pipeline 2026: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight by DelveInsight | Organon, Ironwood Pharma, Mitsubishi Tanabe Pharma, Abbvie - Barchart.com
Endometriosis Pain Pipeline 2026: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight by DelveInsight | Organon, Ironwood Pharma, Mitsubishi Tanabe Pharma, Abbvie Barchart.com
Published: March 4, 2026, 1:30 p.m.
As Women Wait 7–10 Years for Diagnosis, PRM Expands - GlobeNewswire
As Women Wait 7–10 Years for Diagnosis, PRM Expands GlobeNewswire
Published: March 4, 2026, 1:16 p.m.
Link copied to clipboard!